IRS2 and type 2 diabetes mellitus: Importantly, in-vivo inhibition of miR-135a in db/db mice, a T2D mouse model characterized by muscle miR-135a hyperexpression, ameliorated glucose metabolism and improved glucose tolerance through the restoration of IRS2 and of p-AKT expression levels in gastrocnemius skeletal muscle [105].